Clinical Trial Update: A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating rebecsinib in patients with relapsed/refractory secondary acute myeloid leukemia or high-risk myelofibrosis; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelofibrosis

Drugs mentioned

• Rebecsinib (rebecsinib)

Snippet

Sponsor: Aspera Biomedicines, Inc. | Conditions: Secondary AML, Myelofibrosis | Phase 1 | Status: NOT_YET_RECRUITING